webinar register page

Webinar banner
Inflammasome signalling: from fundamental biology to new therapeutics
The inflammasome pathway is a key driver of pathological inflammation, contributing to several common human diseases (e.g. metabolic disease, neurodegenerative diseases, cancers). Inflammasomes are signalling hubs that induce cell lysis, culminating in immune system activation. Here, we reveal new mechanisms by which inflammasomes signal, and how a small molecule inflammasome inhibitor can silence pathological inflammasome signalling for therapeutic management of several human diseases.

The IUIS Webinar Series was established at the beginning of 2020 as an online education programme with the aim to provide individuals from all around the world the opportunity to gain comprehensive knowledge on the latest COVID-19 research developments without the need of travelling in these uncertain times. This first series was a tremendous success: internationally-acclaimed speakers shared their insights and latest research results on COVID-19-related topics in 20 webinars that welcomed more than 8,800 scientists from 86 countries.

For its third series, IUIS, in partnership with immunopaedia and Frontiers in Immunology, will broaden the scope to cover a variety of hot topics in immunological research such as Autoimmunity, Infectious Diseases and Allergology.
Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .